Search

everythinglearnresearchcommunity

for

Search:↓

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

The sebaceous gland has more roles than just producing sebum and contributing to acne, and new research could lead to better skin disease treatments.

No treatment fully prevents hair loss from chemotherapy yet.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Low-dose finasteride may cause lasting sexual dysfunction and suicidal thoughts in young men.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Beta-caryophyllene helps improve wound healing in mice, especially in females.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.